drugset / Trial / NCT01204255
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
Completed
11 enrolled
Virginia Commonwealth University
American Cancer Society, Inc. · collabNational Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelSupportive care
Summary
RATIONALE: Lorazepam, diphenhydramine hydrochloride, and haloperidol gel, when absorbed into the skin, may be an effective treatment for nausea and vomiting.PURPOSE: This clinical trial studies lorazepam, diphenhydramine hydrochloride, and haloperidol gel in healthy volunteers.
Timeline
- Start
- 2010-11-15
- Primary completion
- 2011-04-18
- Completion
- 2011-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diphenhydramine | Small molecule | — | Topical |
| Subject | Haloperidol | Other / unclassified | — | Topical |
| Subject | Lorazepam | Small molecule | — | Topical |
Indications
No indication recorded.